H1 Insights operates a healthcare data analytics platform designed to help companies make informed scientific choices. H1 Insights' platform offers real-time data to support the complete therapeutic development process ranging from fundraising, product development to product launch. This provides the healthcare industry, organizations, and professionals with live, on-demand insights from a myriad data sources. This accelerates the process of discovering and developing therapies to combat diseases.

Investors Include:

Goldman Sachs Asset Management, dRx Capital Novartis, Y Combinator, Free Solo Ventures, Underscore VC, Shore Group Associates, Jeff Hammerbacher, ClearPoint Investment Partners, Goldman Sachs Growth Equity, Baron Davis Enterprises, Novartis Pharma, Mason Plumlee, Liquid 2 Ventures, Lux Capital, Glynn Capital, IVP, Transformation Capital, Menlo Ventures, Flex Capital, Communitas Capital Partners, Lead Edge Capital, Altimeter Capital Management.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more

Our available services for this company

Lifetime IncomeCharitable Remainder Trust

Tax SavingsDonor Advised Fund